228 related articles for article (PubMed ID: 25656734)
1. The risk of pneumococcal infections after immunization with pneumococcal conjugate vaccine compared to non-vaccinated inflammatory arthritis patients.
Nagel J; Geborek P; Saxne T; Jönsson G; Englund M; Petersson IF; Nilsson JÅ; Kapetanovic MC
Scand J Rheumatol; 2015; 44(4):271-9. PubMed ID: 25656734
[TBL] [Abstract][Full Text] [Related]
2. Reduced risk of serious pneumococcal infections up to 10 years after a dose of pneumococcal conjugate vaccine in established arthritis.
Nagel J; Jönsson G; Nilsson JÅ; Manuswin C; Englund M; Saxne T; Kapetanovic MC
Vaccine; 2023 Jan; 41(2):504-510. PubMed ID: 36496283
[TBL] [Abstract][Full Text] [Related]
3. Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors.
Kapetanovic MC; Roseman C; Jönsson G; Truedsson L; Saxne T; Geborek P
Arthritis Rheum; 2011 Dec; 63(12):3723-32. PubMed ID: 21834061
[TBL] [Abstract][Full Text] [Related]
4. The association between antibody levels before and after 7-valent pneumococcal conjugate vaccine immunization and subsequent pneumococcal infection in chronic arthritis patients.
Nagel J; Geborek P; Saxne T; Jönsson G; Englund M; Petersson IF; Nilsson JÅ; Truedsson L; Kapetanovic MC
Arthritis Res Ther; 2015 May; 17(1):124. PubMed ID: 25986458
[TBL] [Abstract][Full Text] [Related]
5. Safety and effectiveness against respiratory tract infections for pneumococcal conjugate vaccine co-administered with routine vaccine combinations.
Adam D; Fehnle K
Vaccine; 2008 Nov; 26(47):5944-51. PubMed ID: 18801402
[TBL] [Abstract][Full Text] [Related]
6. Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme.
Harboe ZB; Valentiner-Branth P; Benfield TL; Christensen JJ; Andersen PH; Howitz M; Krogfelt KA; Lambertsen L; Konradsen HB
Vaccine; 2010 Mar; 28(14):2642-7. PubMed ID: 20096392
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and immunogenicity of pneumococcal vaccination in splenectomized and functionally asplenic patients.
Forstner C; Plefka S; Tobudic S; Winkler HM; Burgmann K; Burgmann H
Vaccine; 2012 Aug; 30(37):5449-52. PubMed ID: 22749594
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with influenza and pneumococcal vaccine uptake among rheumatoid arthritis patients in Denmark invited to participate in a pneumococcal vaccine trial (Immunovax_RA).
Nguyen M; Lindegaard H; Hendricks O; Friis-Møller N
Scand J Rheumatol; 2017 Nov; 46(6):446-453. PubMed ID: 28145151
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of a 7-valent pneumococcal conjugate vaccine (PCV7) and impact on carriage in Venezuelan children at risk of invasive pneumococcal diseases.
Rivera-Olivero IA; Del Nogal B; Fuentes M; Cortez R; Bogaert D; Hermans PW; Waard JH
Vaccine; 2014 Jun; 32(31):4006-11. PubMed ID: 24837505
[TBL] [Abstract][Full Text] [Related]
10. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study.
Miller E; Andrews NJ; Waight PA; Slack MP; George RC
Lancet Infect Dis; 2011 Oct; 11(10):760-8. PubMed ID: 21621466
[TBL] [Abstract][Full Text] [Related]
11. Persistence of antibody response 1.5 years after vaccination using 7-valent pneumococcal conjugate vaccine in patients with arthritis treated with different antirheumatic drugs.
Crnkic Kapetanovic M; Saxne T; Truedsson L; Geborek P
Arthritis Res Ther; 2013 Jan; 15(1):R1. PubMed ID: 23286772
[TBL] [Abstract][Full Text] [Related]
12. Economic evaluation of a universal childhood pneumococcal conjugate vaccination strategy in Ireland.
Tilson L; Usher C; Butler K; Fitzsimons J; O'Hare F; Cotter S; O'Flanagan D; Johnson H; Barry M
Value Health; 2008; 11(5):898-903. PubMed ID: 18489504
[TBL] [Abstract][Full Text] [Related]
13. Pneumococcal antibody levels after pneumovax in patients with rheumatoid arthritis on methotrexate.
Coulson E; Saravanan V; Hamilton J; So KL; Morgan L; Heycock C; Rynne M; Kelly C
Ann Rheum Dis; 2011 Jul; 70(7):1289-91. PubMed ID: 21515601
[TBL] [Abstract][Full Text] [Related]
14. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of a 10- versus 13-valent pneumococcal conjugate vaccine in Denmark and Sweden.
Klok RM; Lindkvist RM; Ekelund M; Farkouh RA; Strutton DR
Clin Ther; 2013 Feb; 35(2):119-34. PubMed ID: 23312274
[TBL] [Abstract][Full Text] [Related]
16. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis.
Kapetanovic MC; Saxne T; Sjöholm A; Truedsson L; Jönsson G; Geborek P
Rheumatology (Oxford); 2006 Jan; 45(1):106-11. PubMed ID: 16287919
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for invasive pneumococcal disease in children in the era of conjugate vaccine use.
Pilishvili T; Zell ER; Farley MM; Schaffner W; Lynfield R; Nyquist AC; Vazquez M; Bennett NM; Reingold A; Thomas A; Jackson D; Schuchat A; Whitney CG
Pediatrics; 2010 Jul; 126(1):e9-17. PubMed ID: 20547641
[TBL] [Abstract][Full Text] [Related]
18. Four years of universal pneumococcal conjugate infant vaccination in Germany: impact on incidence of invasive pneumococcal disease and serotype distribution in children.
van der Linden M; Weiß S; Falkenhorst G; Siedler A; Imöhl M; von Kries R
Vaccine; 2012 Aug; 30(40):5880-5. PubMed ID: 22771186
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales.
Melegaro A; Edmunds WJ
Vaccine; 2004 Oct; 22(31-32):4203-14. PubMed ID: 15474710
[TBL] [Abstract][Full Text] [Related]
20. Invasive pneumococcal infections among vaccinated children in the United States.
Park SY; Van Beneden CA; Pilishvili T; Martin M; Facklam RR; Whitney CG;
J Pediatr; 2010 Mar; 156(3):478-483.e2. PubMed ID: 19962156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
